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In a search for potent inhibitors of glucocerebroside biosynthesis, we synthesized aromatic 
analogs of the enzyme's substrate, ceramide, many of which have not previously been described 
in the literature. Mouse brain and spleen, rat brain, and human placenta and spleen were all 
found to be susceptible to inhibition by a variety of compounds, although to differing extents. 
The most potent inhibitor was 2-decanoylamino-3-morpholino-l-phenylpropanol. The dehydm 
version of this compound (2-decanoylamino-3-morpholinopropiophenone) was less effective but 
it produced inactivation of the enzyme, probably by covalent reaction with the enzyme's active 
site. Examination of the various effects seen leads us to suggest that the active region of the 
enzyme contains four recognitional sites:, an anionic moiety that may bind the glucose in 
activated form, an oxygen-binding region oriented toward the third carbon atom of ceramide, a 
narrow region that binds the alkyl chain of the fatty acid moiety, and a less narrow region that 
binds the hydrocarbon chain of the sphingoid base moiety. 
Introduction 
G l u c o c e r e b r o s i d e  is a w i d e s p r e a d  s p h i n g o l i p i d  t h a t  is b o t h  a m e m b r a n e  
c o m p o n e n t  a n d  a p r e c u r s o r  of  m o r e  c o m p l e x  s p h i n g o l i p i d s .  It is s y n t h e s i z e d  
f r o m  c e r a m i d e  a n d  U D P - g l u c o s e  by  a g l u c o s y l t r a n s f e r a s e  [1,21. S i n c e  t h e  
l ip id  a c c u m u l a t e s  g r e a t l y  in G a u c h e r ' s  d i s e a s e ,  d u e  to  a g e n e t i c  l ack  of  
a d e q u a t e  / 3 - g l u c o s i d a s e  ac t iv i ty ,  it s e e m e d  p o s s i b l e  to  us  t h a t  t h e  s y m p t o m s  
of  t h e  d i s o r d e r  c o u l d  b e  a l l e v i a t e d  by  t r e a t i n g  t h e  v i c t i m s  of  t h e  d i s e a s e  w i t h  
a n  i n h i b i t o r  of  t h e  t r a n s f e r a s e .  L i t t l e  is k n o w n  of  t h e  f u n c t i o n a l  g r o u p s  in 
t h e  a c t i v e  s i t e  of  g l y c o s y l t r a n s f e r a s e s ,  so  d e s i g n i n g  a n  e f f i c i en t  i n h i b i t o r  m u s t  
b e  d o n e  e m p i r i c a l l y .  
T e s t s  in r a t  b r a i n  [3] w i t h  v a r i o u s  a n a l o g s  of  c e r a m i d e  s h o w e d  t h a t  s e v e r a l  
c o m p o u n d s  c o u l d  ac t  as i n h i b i t o r s  of  t h e  g l u c o s y l t r a n s f e r a s e .  T h e  m o s t  
a c t i v e  i n h i b i t o r s  c o n t a i n e d  a b e n z e n e  r i ng  in p l a c e  of  t h e  l o n g  a l k e n e  c h a i n  
of  s p h i n g o s i n e  a n d  a s h o r t  c h a i n  f a t t y  ac id  ( d e c a n o i c )  in p l a c e  of  t h e  
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normally occurring fatty acid (16---24 carbon atoms). The pr imary hydroxyl 
normally present at the terminal position of ceramide could be replaced by a 
hydrogen a tom in the analog while retaining inhibitory activity. The secon- 
dary hydroxyl group at the C-3 position of ceramide proved to be significant: 
if it was in the natural (erythro) configuration with respect to the C-2 amine 
group, it tended to produce activity as a substrate, but if it was absent or in 
the threo configuration, it resulted in inhibitory activity. From these obser- 
vations, it may be concluded that the C-1 group was not important  with 
respect to binding to the enzyme but the C-3 substituent played a crucial 
role in determining whether  the enzyme could act catalytically. 
To extend these observations,  in the hope of synthesizing even more 
active inhibitors, we prepared  and tested additional ceramide analogs, 
emphasizing substituents on the C-I and C-3 carbon atoms that might be 
more reactive. 
Organic syntheses 
Most starting materials were obtained from Aldrich Chemical Co., Mil- 
waukee,  WI or from Eastman Organic, or were described previously [31. 
The products were shown to yield a single spot (in some cases, one or two 
trace spots too) by T L C  on silica gel plates after spraying with a charring 
reagent.  The spots were at approximately the expected location relative to 
related compounds  (e.g.: longer homologs moved faster than shorter ones, 
ketones moved faster than the corresponding 2 ° alcohols) and spraying them 
with ninhydrin or dinitrophenylhydrazine yielded the expected colors. In- 
frared spectra with the KBr pellet method revealed the expected peaks. 
Elemental  analyses were per formed by Sprang Microanalytical Laboratory 
and Galbrai th Laboratories  to confirm the structures; where necessary the 
compounds were recrystallized to bring them within the proper  range of 
analytical values. Where  structural assignments were in doubt,  confirmation 
was obtained by N M R  spectroscopy using tetramethylsilane as internal 
standard. 
Note that the numbering system used for the aromatic  analogs differs 
from that used for the sphingoid b a s e s ) a s  illustrated by DL-2-amino-3- 
hydroxypropiophenone (I)  in the following synthetic route: 
I ( 't,}] 12N4 
~ b - C - - C H 2  
O Br 
¢ b - C - - C H - - C H 2 0 H  
O NHAc  
Ac~O ('H20 
) ' dp-C--CH2 ) q~-C--CH2 
IL t IL I 
O NH2-HC1 O NHAc  
H( "1 / 2 3 
• ~ b - C - - C H - - C H 2 O H  
11 I 
O NH2-HCI 
Compound  I 
NaH('()~ 
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A. Synthesis of 2-amino-3-hydroxypropiophenones 
Compound I was prepared as the hydrochloride from 2-bromo- 
acetophenone by amination with hexamethylenetetramine, acetylation, 
hydroxymethylation with formalin, and deacetylation (see above reaction 
sequence) [4]. p-Substituted derivatives of I were prepared from the cor- 
responding bromoacetophenones, which were purchased or prepared by 
bromination. In the case of methoxyacetophenone, bromination was done 
with methanolic bromine [5]. 
During the hydroxymethylation of 2-acetylamino-p-methylacetophenone, 
some dihydroxymethylation occurred at the C-2 position. The product (m.p. 
164--165°C from EtOAc) was hydrolyzed with HCI and reacylated with 
decanoyl chloride (amide m.p. 143---144.5°C from EtOAc). 
These and other amine hydrochlorides were acylated with acyl chlorides 
in tetrahydrofuran and concd, aqueous NaOAc [6,7]. For the synthesis of 
2,3-epoxydecanoyl L the free acid was coupled to the amine by a mixed 
anhydride method. At -10°C, 0.13 ml of isobutyl chloroformate was added 
to a stirred solution of 1 mmol epoxydecanoic acid [8] and 0.14 ml of Et3N in 
10 ml of tetrahydrofuran. After 5 min of stirring, the mixture was added to a 
suspension of 1 mmol I.HC! and 0.14 ml Et3N in 10 ml tetrahydrofuran, with 
stirring at -10°C. The mixture was then stirred 1 h at 0°C and 30rain at 
22°C. The amide was purified by partitioning between ether and 1% 
NaHCO3 and crystallizing from benzene/hexane. 
In some syntheses, the intermediate 2-aminoacetophenone-HCI was acyl- 
ated with a long chain acyl chloride instead of acetic anhydride, obviating 
the need to deacetylate and reacylate. 
B. Miscellaneous compounds 
N-Decanoyl-p-nitro-I was dehydrated with pyridine/acetic anhydride [9] 
to produce 2-decanoylamino-p-nitroacrylophenone (m.p. 62--63°C from 
hexane). 
2-Decanoylaminopropiophenone was an oil, prepared from N-acetyl-DL- 
norephedrine by oxidation of the hydroxyl group with dichromate [10], 
deacetylation with HCI, and reacylation with decanoyi chloride. It was 
recrystallized from hexane at -20°C. 
2-Acylaminopropiophenones bearing a tertiary amino group at the C-3 
carbon atom were prepared by a Mannich reaction between a secondary 
amine, paraformaldehyde, and 2-acylaminoacetophenone [11]. 
DL-Erythro-3-phenylserine and its ethyl ester were prepared according to 
the method of Bolhofer [12]. The compounds gave the reported melting 
points. Acylation with decanoyl chloride produced the decanoylamino ester 
(m.p. 69°C from benzene/hexane) and the free acid (m.p. 114 115°C). 
Treatment of the amido ester for 2 days with ethanol saturated at room 
temperature with ammonia yielded the carboxamide in 65% yield, m.p. 
177°C from methanol. The decanoylamino ester was converted also to the 
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hydrazide by stirring 1 g of ester with 0.5 ml of hydrazine hydrate in 5 ml of 
methanol for 4h.  The product was recrystallized from boiling methanol: 
m.p. 229-230°C. Like the other inhibitors, it was stored in ch, loro- 
form/methanol,  but a little HCI had to be added to increase its solubility. 
T h e  threo isomer of Dc-phenylserine was purchased from U.S. Biochemicals 
Corp. and converted to the N-decanoyl ethyl ester (m.p. 64 65°C from 
benzene/hexane).  
N-Bromoacetyl  sphingosine, m.p. 84---85°C, was prepared from equi- 
molar quantities of bromoacetyl bromide and D-sphingosine by the NaOAc 
method described above. It was purified by silica gel chromatography using 
chloroform/methanol 99 : I and 99 : 2. 
N-Decylthiocarbamyl norephedrine [ C > H e I - - N H - - C ( : S } - - N H - -  
CH(CH3) - -CHOH--C.Hs]  was made by refluxing equimolar amounts of 
DL-norephedrine and n-decylisothiocyanate in E tOH for 6 h. The solution 
was evaporated to dryness and the residue rccrystallized. 
The tables in the Results section give additional data on the m.p. and 
solvent of recrystallization for the individual compounds. 
Enzyme assays 
Most assays for glucosyltransferase were run with lyophilized brain 
homogenates from 16 day male mice, incubated at 37°C for 90 min [3] with 
0.2/zmol of N-octanoyl  sphingosine or DDS (N-dodecanoyl-l)l.-decasphin- 
ganine or lauroyl e r y t h r o - 2 - a m i n o - l , 3 - d e c a n e d i o l )  as glucose acceptors [S]. 
The compounds tested as inhibitors (generally as 0.3 mM) were evaporated 
to dryness from solution in the incubation tube with the lipoidal substrate 
before adding the lyophilized tissue in benzene and evaporating off the 
solvent. (Because of the toxicity of benzene, the processing must be done in 
a good hood. However  recent work has shown that benzene can be replaced 
by cyclohexane.) The remaining incubation components  (dithioerythritol. 
Tris-C1 pH 7.4 or 7.8, ATP, EDTA,  Mg >, and [3H]UDP-glucose) were then 
added in water. In some experiments, the lipoidal substrate was added in 
liposomal form [8]. The cerebroside formed in the incubation was isolated 
by partitioning between chloroform, methanol, and water. This step [3] was 
simplified by omitting the filtration step for removal of brain nonlipids. The 
lipid thus obtained was assayed by liquid scintillation in a water-containing 
solvent. 
Results 
Amides of 2-amino-3-hydroxypropiophenone (I) 
A comparison of different acyi derivatives of 1, tested at 0.3 mM (Table 1), 
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showed that the decanoyl  c o m p o u n d  (RV-49) was the most  effective and 
that shorter  and longer  homologs  were markedly  less effective. This kind of 
d e p e n d e n c y  on chain length has been  noted  before with several series of 
c o m p o u n d s  tested with enzymes  of sphingol ipid metabol i sm.  Slightly modi-  
fying the 2,3-posit ion of the decanoyl  residue did not affect, or enhanced  the 
inhibi tory  power  of the compound .  Similar results were ob ta ined  with rat 
bra in  glucosyl t ransferase,  using na tura l  ceramides  as substrate .  
Larger  subs t i tuents  on the fatty alkyl chain (the last 5 lines of Table  I) 
reduced  the effectiveness of the basic s tructure.  However  the last compound ,  
in which the b r o m i n e  a tom was far from the amide  link, was relatively 
active, suggest ing that the acyl recogni t ion site in the enzyme loses its 
specificity as the dis tance from the active site increases. Not shown in the 
table are the ra ther  inert  halogen derivat ives of I :  N-chloroacety l  (m.p. 
128-129°C), d ichloroacetyl  (m.p. 134-136°C), and 3 -b romoprop iony l  (m.p. 
K~-84°C) .  
TABLE I 
N-ACYL DERIVATIVES OF 2-AMINO-3-HYDROXYPROPIOPHENONE (I) AS IN- 
HIBITORS OF GLUCOSYLTRANSFERASE IN MOUSE BRAIN 
Assay run with l mg of mouse brain powder, 0.2/xmole DDS, Tris-Cl (pH 7.4), UDP- 
[3H]glucose, and other factors (see text), incubated 90rain at 37°C. Controls synthesized 
1.69nmol of glucocerebroside. Inhibitors were tested at 0.3 raM. The melting points were 
obtained after recrystallizing the samples from EtOAe, benzene, hcxane, or mixtures of these 
solvents. 
M.p. Inhibition 
N-Acyl group (°C) (%. of control) 
Acctyl 114--117 11 
Hexanoyl 6(~-61 22 
Octanoyl 84 44 
Decanoyl (RV-49) 74--75 7(1 
Dodecanoyl 7(~-72 60 
Tetradecanoyl ~ 4 ~ 5  43 
Hcxadecanoyl 90---91 41 
2-Decenoyl 94.5--95.5 79 
2,3-Epoxydecanoyl 90-92 73 
Cinnamoyl 119--119.5 35 
4-Fluorosulfonylbenzoyl 14;"; 2;4 
Bromoacetyl 134~ 135 36 
8- Bromooctanoyl 99-- 100 36 
12-Bromododecanoyl 9(~-91 51) 
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T h e  p resence  of small  subs t i tuen t s  (methyl  and  me thoxy l )  at the  p-  
pos i t ion  of the  pheny l  g roup  had  no effect on the  inh ib i to ry  p o w e r  of RV-49 
(decanoy l  I )  but  l a rger  g roups  (CI, Br,  n i t ro)  r e d u c e d  the ef fec t iveness  
(Table  II). The  2 - h y d r o x y m e t h y l  de r iva t ive  of the first c o m p o u n d  in this 
tab le  was a m o d e r a t e l y  effect ive inh ib i to r  (43%) but  less so than  the 
unsubs t i t u t ed  c o m p o u n d  (68%).  It is in te res t ing  tha t  the  b ind ing  site of the  
enzyme  can a c c o m m o d a t e  the  re la t ive ly  bu lky  side group ,  but  the  resu l tan t  
effect does  not  l ook  useful.  
Subs t i tu t ion  of the  hydroxy l  g r o u p  in RV-49  by h y d r o g e n  (p roduc ing  
N - d e c a n o y l a m i n o p r o p i o p h e n o n e )  r e d u c e d  its inh ib i to ry  p o w e r  only  slightly.  
This  ex t ends  ou r  p rev ious  o b s e r v a t i o n  that  the p r ima ry  O H  g roup  is not  
essent ia l  for  inh ib i to ry  act ivi ty.  The  u n s a t u r a t e d  der iva t ive  of a r e l a t ed  
c o m p o u n d  ( 2 - d e c a n o y l a m i n o - p - n i t r o a c r y l o p h e n o n e ) ,  which also had  no 
t e rmina l  hydroxyl  g roup ,  was even m o r e  act ive than  RV-49  (see Tab le  V 
later) .  
Enzyme  inactivation by a fl-keto alcohol analog 
W e  thought  that  the  ca rbony l  g r o u p  in the  a b o v e  m e n t i o n e d  inh ib i tors  
might  b ind  to the  e n z y m e  in a cova len t  manne r ,  poss ib ly  by fo rming  a Schiff 
base  or  an adduc t  with an act ive amine  g roup  (from lysine or  h is t id ine)  at 
TABLE II 
EFFEC'T OF p-SUBSTITUENTS ON THE PHENYL GROUP OF N-DECANOYL-I (RV- 
49) IN CERAMIDE : GLUCOSYLTRANSFERASE INHIBITION 
Melting points in °C. Assay conditions as in Table 1. The percent inhibitions refer to tests of the 
decanoylamino derivatives. 
M.p. of free M.p. of acetyl M.p. of decanoyl Inhibition 
p-Substituent base.HCI amine amine (%) 
Methyl 169-- 171 12.'9--- 124" 78.--79 68 
Methoxy 18 ."~- 184 12(~ 122 h 83~-84 71 
Chloro 194-- 197 12.~- 126 ~ 9(~-92 46 
Bromo 2(XI 145-- 147 d 92--94 47 
Nitro 179-- 180 164-- 165 ~ 95--96 50 
~Reported m.p. 121°C [15]. 
bReported m.p. 120~122°C [16]. 
CReported m.p. 12~%--126°C [17]. 
dReported m.p. 14.~-147°C [17]. 
eReported m.p. 164---166°C, dec. [4]. 
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the enzyme's active site. A time study with 0.3 mM compound RV-49 (Fig. 
1) showed that the keto alcohol produced a gradually increasing degree of 
inhibition and the transferase was completely inactive after about 60 min of 
exposure to the ketone (as shown by failure of the system to synthesiz6 
additional cerebroside). This type of gradual inactivation had previously 
been observed with a ceramide analog containing the 2,3-epoxydecanoyl 
group [3] and it is possible that both compounds reacted covalently with the 
same reactive group in the enzyme's active site. 
The other curve in Fig. 1 was obtained with 1/2 the concentration of 
inhibitor (0.15 mM), in which case complete inactivation of the enzyme was 
not observed. This phenomenon, which was seen with other inactivating 
inhibitors of the propiophenone series, may be due to gradual loss of inhibitor 
by a competing chemical reaction with other components of the system. 
Acyl derivatives o[ norephedrine 
Our previous study of amides derived from erythro-DL-l-phenyl-2-amino- 
propanol [3] had shown that the decanoyl compound was a strong inhibitor. 









,,~ 06  
S 
60 120 180 24O 
Time (rain) 
Fig. 1. Amount  of cerebroside formed as a function of time in the presence of RV-49 
(2-decanoylamino-3-hydroxypropiophenone). Each incubation tube contained 1 mg of mouse 
brain I~)wder, 0.2 p, mol of N-dodecanoyl decasphinganine, labeled UDP-glucosc, Tris-CI (pH 
7.4), EDTA, dithioerythritol, MgCI:, and ATP. The top curve was obtained from control tubes, 
the middle curve was obtained from tubes containing 0.15 mM inhibitor, and the bottom curve, 
from 0.3 mM inhibitor. Each point is the average derived from three incubation tubes. 
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TABLE 111 
INHIBITION OF MOUSE BRAIN GLUCOSYLTRANSFERASE BY AMIDES OF 
NOREPHEDRINE (ER YTHRO-DL- I-PHENYL-2-AMINO- I-PROPANOL) 
Assays run as in Table I. 
M . p .  Crystallization Inhibition 
N-Acyl group (°C) solvent (%) 
Decanoyl 6'4 70 hcxanc ~2 
2,3-Epoxydecanoyl 9-t--95 benzene/hexanc 72 
Oleoyl 5,~-54 hexane 4'4 
Phenylpropynoyl 146 iso-PrOH 24 
Bromoacetyl 1113~- 1(14 benzene 16 
Dichloroacetyl ~2 benzene/hcxanc I1 
m -Fluorosulfonylbc nzoyl 10t) ,_ II1 benzene 11 
p- F1 uorosulfonylbenzoyl 1 ~2 EtOAc/hcxanc I S 
N-Decylthiocarbamyl 105 benzene (~3 
ca rbon  acid was found  to be the most  act ive.  Ev iden t ly  the b inding  site for 
the  acyl g roup  cannot  read i ly  a c c o m o d a t e  bu lk i e r  groups .  The  decyl-  
t h i o c a r b a m y l  de r iva t ive  r e semble s  the  decanoy l  moie ty  but  it is a bit la rger  
because  of the sulfur  a tom.  This  c o m p o u n d  was not  much less inh ib i tory  and 
it is poss ib le  that  fu r the r  s tudy of the c o m p o u n d  would  show that  it reacts  
cova len t ly  th rough  the sulfur a tom.  
3 - A m i n o  derivatives of  2-decanoylaminopropiophenone 
The  p romis ing  ac t ion  of the 3 -hydroxy  c o m p o u n d s  (Table  I) was s tud ied  
fu r the r  by p r e p a r i n g  amine  analogs .  W e  knew [3] that  a s econda ry  a m i n o  
g roup  near  the  t e rmina l  ca rbon  (actual ly  at the  C-2 pos i t ion)  d id  not  affect 
the  deg ree  of inhibi t ion .  M o r e o v e r  it was known that  /3-amino ke tones  are 
re la t ive ly  react ive ,  gene ra t i ng  reac t ive  p roduc t s  which might  form cova len t  
de r iva t ives  with the g lucosy l t r ans fe rase .  
W e  the re fo re  syn thes ized  [ t l ]  some  te r t i a ry  amine  der iva t ives  of 2- 
d e c a n o y l a m i n o p r o p i o p h e n o n c  f rom m o r p h o l i n e  (RV-378),  4 -me thy lp ipe raz -  
ine (m.p.  135--137°C),  N - m e t h y l - a m i n o e t h a n o l  (m.p.  9 l - - t )3°C) ,  and 
p ipe r id ine  (RV-471).  The  first three  c o m p o u n d s  were  crys ta l l ized  as the 
h y d r o c h l o r i d e s  and the last as the salt of p - t o lue ne su l fon i c  acid,  which was 
itself inert  in the t r ans fe rase  assay.  The  second  and third amines  were  less 
pure  and were  not checked  by e l emen ta l  ana lyses  or  s tud ied  in dep th .  The  
a m i n o  ke tones  were  uns tab le  in sil ica gel co lumns  when c h r o m a t o g r a p h e d  
with neut ra l  solvents ,  and T L C  with neut ra l  or  a m m o n i a c a l  so lvents  
p r o d u c e d  s t reaking .  H o w e v e r  good  T L C  pla tes  were  o b t a i n e d  with ch loro-  
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form/methanol/acet ic  acid (90:5:10)  the R F  values being 0.68, 0.26, 0.15, 
and 0.55, respectively. 
Tested at 0.3 mM, the amines produced 86 to 95% inhibition. The acetyl 
homolog of RV-378 yielded only 14% inhibition, showing here too the 
importance of chain length in the acyl group. 
Increasing the concentration of the lipoidal substrate, octanoyl sphin- 
gosine, did not protect the enzyme against inhibition by RV-378, the 
morpholino ketone (Table IV). It did, however, produce distinct protection 
against .the weaker inhibitors, decanoyl norephedrine and RV-49. Note that 
RV-378 was tested at a lower concentration than the other two and that the 
usual concentration of octanoyl sphingosine in our assay system is 1 mM. 
These competitive effects support the expectation that the ceramide analogs 
bind to the ceramide-binding site and that the amino ketone binds somewhat 
more firmly. 
Reduction of the ketone group in RV-378 produced a mixture of erythro 
and threo isomers (RV-538) that proved to be an even more effective, very 
potent  inhibitor. However  the reduced amino ketone affected the enzyme by 
a different mechanism (Fig. 2). Except for the first time point, the hydroxy 
morpholino compound produced a constant degree of inhibition, consistent 
with the idea that it is a reversible inhibitor. The ketone, on the other hand, 
behaved like RV-49 (Fig. l) and simply inactivated the enzyme. At 0.15 mM 
RV-378, the enzyme became inactivated during the first 80 min of contact. 
In the above experiment we used wet brain homogenate and the substrate 
(DDS) was added in liposomal form [8]. The effectiveness of RV-378 in this 
incubation system was lower than in the usual incubations, in which the 
TABLE IV 
PROTECI ' ION OF MOUSE BRAIN GLUCOSYLTRANSFERASE BY SUBSTRATE 
(OCTANOYL SPHINGOSINE)  
"'Dec" is the decanoyl group. The first two inhibitors were tested at {).15 mM and the third, at 
75/.zM. The amount of cerebroside formed is in the units, nmol/90 rain. 
Inhibitor Cerebroside Inhibition 
synthesized (%) 
Substrate conc.: {).5 mM 3 mM {I.5 mM 3 mM 
Controls 1.93 
Phe ny I - -CH(OH)- -CH(NH Dec)~CH3 {I.86 
P h e n y I - - C ( = O ) - - C H ( N H D e c ) - - C H 2 O H  0.93 
P h e n y l - - C ( = O ) - - C H ( N  HDec)---CH ~--morpholine 1.31 
2.22 - -  - -  
1.51 56 32 
1.68 52 24 
1.57 32 29 







60  120 
Time ( min ) 
Fig. 2. Amount of glucocerebroside formed in the presence of two related morpholino 
decanoy/amino derivatives. Each incubation tube contained 6 mg of homogenized mouse brain, 
the factors listed in the legend to Fig. 1, and 0.2tzmol of dodecanoyl decasphinganine in 
liposomes formed with 565,~g of lecithin and 100,ttg of cerebroside sulfate, Na salt. The 
topmost curve was derived from control incubations, the middle curve was obtained with 
0.15mM 2-decanoylamino-3-morpholinopropiophenone, and the lowest curve was obtained 
with its reduction product, 0.15 mM 2-decanoylamino-3-morpholino-l-phenylpropanol. 
inh ib i tor  made  contact  with the lyophil ized tissue while in benzene .  
Eviden t ly  the lat ter  condi t ion  p roduced  be t te r  contact  be tween  enzyme and 
inhibi tor .  The  difference in effectiveness be tween  the two incuba t ion  con- 
di t ions  was even greater  when  less soluble inhibi tors  were tested. 
Tests at lower concentrations 
Many  of the t ransferase inhibi tors  were tested at concen t ra t ions  below 
0.3 m M  to clarify their  relat ive degrees of effectiveness (Table V). The 
s t rongest  inhibi tors  at 0 . 1 5 m M  were RV-441 (decanoyl  norephedr ine) ,  
RV-378,  RV-471,  and  RV-538. Tes ted  at 37.5/zM, the first two of these were 
much less po ten t  but  the p iper id ino  ke tone  and reduced RV-378 were still 
very active. It is curious that some inhibitors ,  at the lowest concen t ra t ion  
tested,  actually seemed to stimulate the enzyme.  
Not  shown is a test with mouse  spleen (1 mg of lyophil ized tissue) and 
DDS,  which yielded 1.27 nmol  of cerebroside  in 90 min. The  effectiveness of 
the var ious inhibi tors  was similar to that seen with brain ,  a l though some 
inhibi tors  were more  effective in one  organ than in the other.  This  may 
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TABLE V 
INHIBITION OF GLUCOSYLTRANSFERASE BY CERAMIDE ANALOGS TESTED AT 
LOWER CONCENTRATIONS (150 AND 37.5 tzM) 
Assays run with mouse brain powder and DDS as described in text. "Dcc"= the decanoyl 
group. A plus sign indicates increased glucolipid formation. 
Inhibition 
(% of control) 
Inhibitor 150/~M 37.5 #M 
PhenyI--C(~O)--CH(NHDec)--CH2OH (RV-49) 30 + 15 
p-CH30----phenyI--C(~O)---CH(NHDec )---CH2OH 28 +24 
PhenyI--C(~O)----CH(NHDec)--CH3 24 + 17 
p -Nitro-phe nyI--C(=O)---C(N HDec)==CH2 40 + 1(I 
PhenyI--CH (OH)--CH(NHDec)--CH3 (RV-441) 65 15 
PbenyI--C(~O)--CH(NHDec)--CH~-morpholine (RV-378) 72 34 
PhenyI--CH (OH)--CH(NHDec)--CH ~-morpholine (RV--538) 94 84 
Phenyl--C(~O)---CH (NHDec)---CH-~-piperidine (RV-471) 89 63 
PhenyI--CH(OH)~CH(N HDec)---COO Et 50 6 
N-Bromoacetyl sphingosine 49 
TABLE VI 
INHIBITION OF HUMAN TISSUE GLUCOCEREBROSIDE BIOSYNTHESIS, IN 
PLACENTA AND GAUCHER SPLEEN 
Assays were run with 1.5 mg of lyophilized tissue with DDS as substrate, at pH 7.8 for 90 min. 
(This weight falls within the linear region of activity versus tissue weight.) The control 
activities were 0.81 nmol cerebroside formed by spleen and 0.54 nmol formed by placenta. For 
structures of inhibitors see Table V (PP = propiophenone; PL = phenylpropanol). 
Inhibition (%) 
Inhibitor Placenta Spleen 
RV-378 [decanoylamino-morpholino-PP] (150 p,M) 
RV-378 [decanoylamino-morpholino-PP] (37.5 p,M) 
RV-471 [decanoylamino-morpholino-PL] (150/zM) 
RV-471 [decanoylamino-morpholino-PL] (37.5/,tM) 
RV-49 [decanoylamino-hydroxy-PP] (300/,tM) 
RV-49 [decanoylamino-hydroxy-PP) (150/zM) 
RV-441 [decanoylamino-PL] (300/xM) 
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TABLE VII 
N - D E C A N O Y L  E R Y T H R O - P H E N Y L S E R I N E  DERIVATIVES AS INHIBITORS OF 
MOUSE BRAIN GLUCOSYI .TRANSFERASE 
Assayed with mouse brain powder and DDS as in the text. 
( ' , ,H~- -CH--CH--R 
I t 
OH N H - - C ( = O ) - - ( ' , , H  i, 
Crystallization M.p. Inhibition 
R group solvent (o(,) (%) 
COOH benzene 114~ 115 34 
COOEt  bcnzenc/hcxane 60 74 
CONH2 methanol 177 14 
CONHNH2 methanol 23(1 ,',; 
indicate the existence of different types of glucosyltransferasc in the two 
organs; we had previously seen other differences between the glucosyltrans- 
ferases of mouse liver and brain [8]. 
Since the primary goal of this project was to develop inhibitors that wcrc 
effective in human (Gaucher)  tissues, we examined some of the compounds 
with human placenta and Gaucher  spleen (Table VI). All showed promising 
activity, with greater  effectiveness in the spleen. As noted above, such 
differences could indicate that the two tissues contain transferases with 
different properties.  
Derivatives of N-decanoyl-Dz.-erythro-3-phenylserine 
The free erythro acid showed some inhibitory activity but the amide and 
hydrazide were rather inert (Table VII). The ethyl ester, however,  was quite 
a strong inhibitor. Unexpectedly,  the N-decanoyl  derivative of the threo 
amino acid, ethyl ester, was a little less effective than the erythro isomer. 
D i s c u s s i o n  
The experiments  described above contribute additional information about 
the nature of the active site in ce ramide :UDP-glucose  glucosyltransferase. 
Ceramide analogs seem to bind to the active site that normally binds the 
lipoidal substrate, ceramide. Replacement  of the primary O H  of the 
ceramide analogs with a hydrogen a tom or larger group does not appreci- 
ably block binding. When the larger group is an amine, the analog's 
effectiveness increases considerably, suggesting that there is an anionic 
group in the active site. This could be a thiol, carboxyl, or phosphate group, 
any of which could form a glucoside of high energy by reaction with 
UDP-glucose,  and then pass on the sugar residue to ceramide. 
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Supporting the idea of an anionic site is the observation (Table VII) that 
decanoyl phenylserine (the free acid) was a weak inhibitor while its ethyl 
ester was a strong one. One would expect that an anionic site would repel a 
negatively-charged analog of ceramide but not a nonionic analog. 
The hydroxyl or carbonyl group in the C-3 position of ceramide (C-1 of 
the aromatic analogs) was also of high significance to the enzyme's binding 
site. Reduction of the carbonyl group to a hydroxyl considerably enhanced 
the compound's  potency, both in the case of the nonionic RV-49 and the 
cationic RV-378. Evidently there is a region close to the active site of the 
enzyme that can form a strong bond with the hydroxyl group. However  the 
ketonic oxygen seems to have a particular role in producing inactivation of 
the enzyme. 
One explanation for this role is that the keto amine or alcohol binds to the 
active site, then a/3-elimination reaction expels the C-3 group and the C-2 
hydrogen, forming water or a secondary amine (e.g.: morpholine) and 
2-decanoylaminoacrylophenone.  A Michael addition reaction could then 
occur in which a nucleophilic group in the active site would add to the 
double bond in the acrylophenone. The proposed nucleophilic group could 
be the postulated anionic group (SH, COOH,  PO4) or an amine ( lysine)or  
imidazole (histidine). However,  the latter groups would probably have a 
positive charge at the pH used in our incubations and would be expected to 
repel the highly effective cationic inhibitors. 
The above hypothesis explains why RV-49 is less potent  than RV-378, 
since 13-keto alcohols are more stable at neutral pH than /3-keto amines. 
The ketone lacking a polar group at the 3-position (decanoylamino- 
propiophenone)  was even less effective and did not produce complete 
enzyme inactivation even when incubated for a long time. This compound 
would not be expected to spontaneously form an acrylophenone. 
Support for the proposed elimination reaction comes from the work of 
Sch6nenberger et al. [13], who showed that aromatic /3-amino ketones 
undergo spontaneous elimination of the amine moiety in neutral solution, 
with formation of the acrylophenone. A wide range of biological activities 
was exhibited by the compounds studied and the authors proposed a 
mechanism of action similar to the one above. 
These authors also observed a second reaction with the aromatic amino 
ketones, a hydrolytic cleavage in which formaldehyde and the amine were 
formed (a reversal of the organic synthesis). Formaldehyde,  like acrylo- 
phenones, is highly reactive and could inactivate the enzyme. Either reaction 
might be catalyzed by the enzyme, making this a possible example of 
'active-site-directed irreversible enzyme inhibition' [14]. 
The relative bulkiness of the amine group in RV-378 and related com- 
pounds may act to enhance binding to the enzyme because of the steric 
resemblance to the glucose residue that becomes attached to that position in 
the normal mode of enzyme reaction. 
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One might postulate that the ketonic enzyme inhibitors act, not by 
forming a covalent linkage with the enzyme's active site, but by binding 
somewhere else, deforming the enzyme molecule sufficiently to make it 
thermally unstable. However,  in several instances the reduced (hydroxylic) 
analog was more effective than the original ketone, yet it did not produce 
inactivation (Fig. 2). 
The most active compound we made, RV-538, is probably more active 
than it seems since it contains the erythro form, which is probably less potent 
than the threo form. If the compound were to be administered in vivo, part 
of it might be oxidized enzymatically to the ketone (RV-378), thus giving it 
dual modes of action. Experiments in progress have shown that RV-378 is 
active in mice, producing inactivation of liver glucosyltransferase. It is also a 
relatively effective inhibitor of monoamine oxidase in mice [11], which 
complicates the therapeutic implications. 
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